Minoxidil biorga laboratoires bailleulsoluz cutaneous 60 ml

Minoxidil biorga laboratoires bailleulsoluz cutaneous 60 ml

LABORATOIRES BAILLEUL-BIORGA

SKU
042311011
Special Price €28.75 Regular Price €37.50 Save... €8.75 -23%
Recent lowest price:   €29.88
In stock
icomoon-up
icomoon-down

Cutaneous solution indicated for the treatment of alopecia.

Composition: Minoxidil 50 mg / ml (5% w / v). One delivery of 5% cutaneous solution of Minoxidil Biorga contains 7 mg of minoxidil. Seven puffs are required to apply approximately 1 ml of solution containing 50 mg of minoxidil. Excipient with known effects: propylene glycol.

Contraindications: Hypersensitivity to the active substance or to any of the excipients. The solution is not indicated in cases of sudden or unexplained hair loss. It should also not be used if hair loss is associated with pregnancy, childbirth or serious medical conditions, such as thyroid malfunction, lupus, loss of hair sections associated with inflammation of the scalp or other conditions.

Posology The dose of 1 ml should be applied to the scalp twice a day (once in the morning and once in the evening). This dose should be administered regardless of the size of the affected area. The total daily dose should not exceed 2 ml. Pediatric population and elderly population Not recommended under 18 years and above 65 years of age due to the lack of data on safety and efficacy. Method of administration for external use only. It is not recommended under 18 and above 65 years of age due to the lack of data on safety and efficacy. It should be applied according to the instructions and on the scalp only, and should only be applied to dry hair and scalp. You may need to apply the product twice a day for four or more months. In any case, the physician should consider stopping the treatment if no results are observed within 4 months. If hair regrowth is observed, the application must be continued twice a day, to maintain its effects. After discontinuation of topical minoxidil treatment, hair regrowth has occasionally stopped and returned to its former appearance within 3–4 months after discontinuation of treatment.

Warnings and precautions for use: Patients with known cardiovascular disease or cardiac arrhythmia should consult a physician before using the solution. It is not indicated in the absence of a family history of hair loss, sudden and / or patchy hair loss, hair loss due to childbirth or when the cause of hair loss is unknown. It should only be applied to a normal, healthy scalp. Do not use if the scalp is red, inflamed, irritated or painful or if you are using other medicines to apply to the scalp. Some excipients of the solution can cause burning and irritation. In case of accidental contact with sensitive surfaces (eyes, abraded skin and mucous membranes), the area should be washed with plenty of fresh tap water. You should avoid inhaling the spray. Do not swallow. The patient should stop using the solution and consult their doctor if they experience hypotension or experience chest pain, rapid heart rate, fainting or dizziness, sudden weight gain, swelling of the hands or feet, and persistent redness or irritation of the scalp. . Some patients have experienced changes in hair color and / or texture with use. Pediatric population Accidental ingestion can cause serious cardiac adverse events. Therefore, it must be kept out of the reach of children.

Interactions: Pharmacokinetic interaction studies conducted in humans revealed that the percutaneous absorption of minoxidil is increased by tretinoin and anthralin as a consequence of the increased permeability of the stratum corneum; betamethasone dipropionate increases the concentration of minoxidil in local tissues and reduces its systemic absorption.

Pregnancy and lactation: Pregnancy There have been no adequate and well-controlled studies in pregnant women to date. Animal studies have revealed a risk to the fetus at exposure levels that are very high compared to those intended for human exposure. A low risk of fetal harm is possible, although remote, in humans (see section 5.3 Preclinical safety data). Breastfeeding Systemically absorbed minoxidil is excreted in breast milk. Topical minoxidil should only be used during pregnancy or breastfeeding if the benefit to the mother outweighs the risks to the fetus or infant.

Flammable product. Protect from heat. Keep container tightly closed.

Destination Cost Detail
Italy €5,90 24/72H
Austria, Belgium, France, Germany, Netherlands, Poland, Czech Republic € 12* 3 days
Denmark,Luxembourg,Portugal,Slovakia,Spain,Hungary € 16* 4 days
Bulgary,Croatia,Estonia,Finland,Greece,Ireland,Lithuania,Romania,Slovenia,Sweden € 27* 5 days
Canada, Switzerland, United Kingdom, USA € 45 7 Days

National shipments with express courier: Bartolini, GLS
European shipments with express courier: FedEx, MBE, DHL
*For the shipment outside band B ther's an extra cost of 20€
*For the shipment outside band C ther's an extra cost of 30€
Delivery Times exclude Saturday and Holidays
For Islands and Areas of difficult Accessibility the shipments are made in 72 hours and the cost will be increased by 15€
The images of the products shown on our site are purely indicative and may differ in shape, color, text and packaging shown on them. Given the difficulty of updating all the products on our site in real time or any errors, XFarma.it, all products will be identified through SKU MINSAN (code of the Ministry of Health).